Erik Trock-Jansen
Amministratore Delegato presso NOVIMMUNE SA
Profilo
Erik Trock-Jansen is currently the Chief Executive Officer at NovImmune SA since 2018.
Prior to this, he was the Chairman at Tytex A and the President at Vernal AG.
Posizioni attive di Erik Trock-Jansen
Società | Posizione | Inizio |
---|---|---|
NOVIMMUNE SA | Amministratore Delegato | 01/08/2018 |
Precedenti posizioni note di Erik Trock-Jansen
Società | Posizione | Fine |
---|---|---|
Tytex A/S
Tytex A/S TextilesProcess Industries Tytex A/S provides medical textile products. Its products include continence care post surgery, ostomy and hernia, wound dressing and IV fixation, hip protection and pregnancy & nursing. The company was founded in 1971 and is headquartered in Ikast, Denmark. | Presidente | - |
Vernal AG
Vernal AG TextilesProcess Industries Vernal AG operates as a holding company with interests in manufacturing of technical and specialty nonwovens through its subsidiary companies. The company is headquartered in Allschwil, Switzerland. | Presidente | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Tytex A/S
Tytex A/S TextilesProcess Industries Tytex A/S provides medical textile products. Its products include continence care post surgery, ostomy and hernia, wound dressing and IV fixation, hip protection and pregnancy & nursing. The company was founded in 1971 and is headquartered in Ikast, Denmark. | Process Industries |
Vernal AG
Vernal AG TextilesProcess Industries Vernal AG operates as a holding company with interests in manufacturing of technical and specialty nonwovens through its subsidiary companies. The company is headquartered in Allschwil, Switzerland. | Process Industries |
Novimmune SA
Novimmune SA Medical/Nursing ServicesHealth Services Novimmune SA discovers and develops antibody-based drugs targeted for the treatment of inflammatory diseases, immune-related disorders and cancer. The company was founded by Bernard Mach in 1998 and is headquartered in Plan-les-Ouates, Switzerland. | Health Services |
- Borsa valori
- Insiders
- Erik Trock-Jansen